A New Approach to Cortisol Dosing for Adrenal Insufficiency

For a patient with adrenal insufficiency, the body’s inability to produce cortisol is more than a clinical deficit; it is a precarious tightrope walk. During a severe viral infection like COVID-19, where fever and malaise demand a constant immune response, that tightrope can fray. Standard "sick day rules"—simply doubling a morning and evening dose—may leave patients dangerously exposed during the darkest hours of the night.

The Flaw in the Current Model

New mathematical modeling suggests that the traditional way we dose hydrocortisone is fundamentally ill-equipped for the sustained "inflammatory storm" of a major illness. By treating the human body as a complex fluid-dynamic system, the study reveals that the secret to preventing a life-threatening adrenal crisis may not just be how much medicine a patient takes, but how frequently they take it.

How the Research Was Conducted

The researchers developed a non-linear system to track how oral hydrocortisone moves from the gut into the blood, specifically accounting for how the drug binds to proteins. Key parameters for their model included:

Fitted binding protein level ( $B_0$ ): 1026 nmol/L
Absorption rate ( $k_{abs}$ ): 0.59 h⁻¹
Excretion rate ( $k_{ex}$ ): 1.7 h⁻¹

Using these, the model simulated what happens when patients use standard regimes (like 15–10 mg) versus a more aggressive 6-hourly dosing (qds) schedule.

Key Findings of the Study

The Hidden Danger of Standard Dosing

The results expose a significant vulnerability in standard care. Under typical dosing, patients experience a critical early morning "nadir"—a rhythmic low point between 04:00 and 07:00 where cortisol levels bottom out. In the context of a high-stress infection, this gap is a window of extreme vulnerability.

The Superiority of 6-Hourly Dosing

The model proved that switching to a 6-hourly (qds) schedule (e.g., 10, 20, or 30 mg doses) effectively eliminated the morning nadir. This creates a stable pharmacological shield that closely mimics a continuous intravenous infusion.

Important Considerations and Limitations

While the simulations offer a breakthrough in "in-silico" medicine, the authors urge a measured interpretation.

Model Predictions vs. Reality

The mathematical model showed some variance when compared to real-world data:

It under-predicted concentration peaks by about 25% at lower doses.
It over-predicted peaks by about 25% at a 50 mg dose level.

Unmodeled Complexities

The current math does not yet account for other critical factors that could alter outcomes:

How a high fever might change drug metabolism.
How variables like age and sex affect the way the body processes steroids.

The Clinical Takeaway

Despite these complexities, the narrative for clinical care is shifting. During the relentless stress of a viral infection, any gap in coverage is a risk. Shifting to broad, 6-hourly coverage could be the key to keeping the body’s defenses standing until the fever breaks.

Reference: Modelling oral adrenal cortisol support; David J. Smith, Alessandro Prete, Angela E. Taylor, Niki Karavitaki, and Wiebke Arlt. arXiv:2006.00043v1 [q-bio.TO] (May 29, 2020).